Johnson & Johnson Consumer to introduce CYTOMIMIC Technology at 68th AAD meeting

Building on decades of research into how the body's electrical field affects skin regeneration, scientists at Johnson & Johnson Consumer Companies, Inc., have discovered how to harness the power of bioelectricity to help improve skin rejuvenation.  The new innovation, called CYTOMIMIC™ Technology, is a proprietary, patented technology that combines essential minerals to deliver biological levels of electric signals similar to the skin's natural bioelectricity. CYTOMIMIC™ Technology will be introduced to the dermatologic community and featured in nine scientific posters at the 68th Annual Meeting of the American Academy of Dermatology (AAD), March 5-9, 2010, at the Miami Beach Convention Center.

"CYTOMIMIC™ Technology mimics the body's natural bioelectricity to help rejuvenate, repair and renew skin," says Dr. Ying Sun, a Distinguished Research Fellow and Science Leader for an internal growth platform venture at Johnson & Johnson Consumer Companies, Inc. "We combine essential minerals in a first-of-its-kind delivery system to deliver biological levels of electric signals similar to the skin's natural bioelectricity."

The clinical studies that demonstrate improvement of the skin's appearance starting within minutes of application with continued improvements over time have been accepted and will be on display at what is considered the largest and most prestigious gathering of dermatologists. With more than 19,000 physicians from around the world attending the Annual Meeting in 2009, this yearly gathering's stated objective is to link research and clinical findings to practice, with the ultimate goal to advance dermatology care.

The scientific posters that feature CYTOMIMIC™ Technology include:

• Biomimetic Electricity Generated by an Elemental Bi-mineral Complex Produces Anti-Inflammatory Activity
• Biomimetic Electricity Generated by an Elemental Bi-mineral Complex Increases Extracellular Matrix Production in Human Skin Explants
• Biomimetic Electricity Generated by an Elemental Bi-mineral Complex Inhibits Melanogenesis via Suppressing Tyrosinase Expression
• Safety and Tolerability of a Topical Bi-mineral Complex that Generates Biomimetic Signals
• Biomimetic Signaling Technology Generated by a Bi-mineral Complex Demonstrates Efficacy in Reducing Clinical Photo-aging in a 12-Week Placebo-Controlled Study
• Biomimetic Signaling Technology Generated by a Bi-mineral Complex Reduces Signs of Photo-aging in the Eye Area
• A Cosmetic Product Containing Biomimetic Signaling Technology to Improve the Aging Signs in the Eye Area
• Clinical Improvements in Facial Photo-Aging with Topical Application of a Biomimetic Mineral Complex and Naturals Extract Formulation
• Facial Moisturizer Featuring Biomimetic Signaling Technology from a Bi-mineral Complex Reduces Skin Laxity

The abstracts will be displayed as electronic posters in Poster Exhibit Hall D. One of the abstracts has the added distinction of also being selected for a Poster Discussion. "Biomimetric Signaling Technology Generated by a Bi-mineral Complex Demonstrates Efficacy in Reducing Clinical Photo-aging in a 12-Week Placebo-Controlled Study," Poster P304, will be presented on Sunday, March 7th from 7:25 -7:35 a.m. in Room D229/230.

This patented technology was discovered in 2004 by Dr. Sun and his colleagues Dr. Jue-Chen Liu and Jeannette Chantalat. Today, Johnson & Johnson Consumer Companies holds 10 U.S. patents active until 2023 and has multiple U.S. and international applications pending.

SOURCE Johnson & Johnson Consumer Companies, Inc.